Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Renografin-76
Known as:
renografin 76
National Institutes of Health
Create Alert
Related topics
Related topics
2 relations
Broader (2)
Uropolin
urovision
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Contrast media-related complications during cardiac catheterization using Hexabrix or Renografin in high-risk patients.
R. Feldman
,
D. A. Jalowiec
,
J. Hill
,
C. Lambert
The American journal of cardiology
1988
Corpus ID: 37835010
Contrast media may lead to adverse reactions during cardiac catheterization. Hexabrix has less hemodynamic and electrophysiologic…
Expand
Highly Cited
1985
Highly Cited
1985
Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography.
E. Gertz
,
J. Wisneski
,
D. Chiu
,
J. R. Akin
,
C. Hu
Journal of the American College of Cardiology
1985
Corpus ID: 42160159
The hemodynamic and electrophysiologic alterations induced by ionic contrast agents during cardiac angiography are well described…
Expand
Highly Cited
1985
Highly Cited
1985
Ventricular fibrillation during coronary angiography: an analysis of mechanisms.
D. Murdock
,
D. Euler
,
D. Becker
,
J. Murdock
,
P. Scanlon
,
R. Gunnar
American heart journal
1985
Corpus ID: 6958892
To investigate the mechanisms of ventricular fibrillation (VF) during coronary angiography, we assessed ventricular automaticity…
Expand
1983
1983
Changes in QTc interval induced with Renografin-76 and Hypaque-76 during coronary arteriography.
G. Wolf
,
J. Hirshfeld
Journal of the American College of Cardiology
1983
Corpus ID: 19538580
Renografin-76 and Hypaque-76 are both recommended for coronary arteriography. Both have the same osmolality and iodine…
Expand
Highly Cited
1983
Highly Cited
1983
Hemodynamic and electrocardiographic effects in man of a new nonionic contrast agent (iohexol): advantages over standard ionic agents.
G. Mancini
,
J. Bloomquist
,
+5 authors
C. Higgins
The American journal of cardiology
1983
Corpus ID: 1895184
Iohexol is a new, nonionic contrast material that has been shown in animal studies to hold great promise as an agent for coronary…
Expand
Highly Cited
1982
Highly Cited
1982
Evaluation of the hemodynamic effects of intravenous administration of ionic and nonionic contrast materials. Implications for deriving physiologic measurements from computed tomography and digital…
C. Higgins
,
K. Gerber
,
R. Mattrey
,
R. Slutsky
Radiology
1982
Corpus ID: 36375382
The effects of intravenous injection of an ionic contrast material (Renografin-76 [meglumine sodium diatrizoate]) on left…
Expand
Highly Cited
1978
Highly Cited
1978
Identification and Description of Separate Mechanisms for Two Components of Renografin Cardiotoxicity
K. Popio
,
Albert Ross
,
J. Oravec
,
J. Ingram
Circulation
1978
Corpus ID: 244027
SUMMARY Both hemodynamic and electrocardiographic effects of Renografin-76 (diatrizoate meglumine) were studied in intact…
Expand
1978
1978
Reduction in ventricular fibrillation using calcium-enriched Renografin 76.
K. R. Thomson
,
M. Violante
,
T. Kenyon
,
H. W. Fischer
Investigative radiology
1978
Corpus ID: 22330419
Renografin 76 has been shown to have significant calcium-binding properties in vivo and in vitro. Two contrast media solutions…
Expand
1971
1971
Evaluation of Renografin M-76 as a contrast agent for angiocardiography.
F. Hildner
,
B. Scherlag
,
P. Samet
Radiology
1971
Corpus ID: 12299526
Cardiovascular and electrophysiological effects of two contrast agents were evaluated during and after ventriculography…
Expand
Highly Cited
1968
Highly Cited
1968
Purification of competent cells in the Bacillus subtilis transformation system.
C. Hadden
,
E. Nester
Journal of bacteriology
1968
Corpus ID: 32817685
Transformed cells have been separated from nontransformed cells by centrifugation on a density gradient of Renografin-76…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE